Neurodegenerative diseases and neuroinflammation-induced apoptosis.

Shi Huang, Yaxin Lu, Wanzhen Fang, Yanjiao Huang, Qiang Li, Zhiliang Xu
Author Information
  1. Shi Huang: School of Clinical Medicine, Wannan Medical College, 241002, Wuhu, Anhui, China.
  2. Yaxin Lu: School of Pharmaceutical Sciences, Wannan Medical College, 241002, Wuhu, Anhui, China.
  3. Wanzhen Fang: School of Stomatology, Wannan Medical College, 241002, Wuhu, Anhui, China.
  4. Yanjiao Huang: Human Anatomy Experimental Training Center, School of Basic Medical Science, Wannan Medical College, 241002, Wuhu, Anhui, China.
  5. Qiang Li: Human Anatomy Experimental Training Center, School of Basic Medical Science, Wannan Medical College, 241002, Wuhu, Anhui, China.
  6. Zhiliang Xu: Department of Human Anatomy, School of Basic Medical Science, Wannan Medical College, 241002, Wuhu, Anhui, China.

Abstract

Neuroinflammation represents a critical pathway in the brain for the clearance of foreign bodies and the maintenance of homeostasis. When the neuroinflammatory process is dysregulate, such as the over-activation of microglia, which results in the excessive accumulation of free oxygen and inflammatory factors in the brain, among other factors, it can lead to an imbalance in homeostasis and the development of various diseases. Recent research has indicated that the development of numerous neurodegenerative diseases is closely associated with neuroinflammation. The pathogenesis of neuroinflammation in the brain is intricate, involving alterations in numerous genes and proteins, as well as the activation and inhibition of signaling pathways. Furthermore, excessive inflammation can result in neuronal cell apoptosis, which can further exacerbate the extent of the disease. This article presents a summary of recent studies on the relationship between neuronal apoptosis caused by excessive neuroinflammation and neurodegenerative diseases. The aim is to identify the link between the two and to provide new ideas and targets for exploring the pathogenesis, as well as the prevention and treatment of neurodegenerative diseases.

Keywords

References

  1. Cells. 2022 Jan 21;11(3): [PMID: 35159168]
  2. J Inflamm (Lond). 2023 Oct 12;20(1):33 [PMID: 37828492]
  3. Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4971-4982 [PMID: 32075919]
  4. Int J Mol Sci. 2020 Feb 07;21(3): [PMID: 32046139]
  5. Alzheimers Dement. 2021 Feb;17(2):316-317 [PMID: 33047474]
  6. Neurotherapeutics. 2022 Jan;19(1):173-185 [PMID: 34729690]
  7. Mol Neurobiol. 2022 Jan;59(1):354-385 [PMID: 34699027]
  8. Methods Mol Biol. 2013;1017:229-39 [PMID: 23719920]
  9. Free Radic Biol Med. 2012 May 1;52(9):1734-43 [PMID: 22387176]
  10. Neural Regen Res. 2024 Sep 1;19(9):1961-1966 [PMID: 38227522]
  11. J Dent Res. 2011 Apr;90(4):417-27 [PMID: 20940366]
  12. Vitam Horm. 2014;96:211-45 [PMID: 25189389]
  13. Semin Cell Dev Biol. 2020 Feb;98:139-153 [PMID: 31154010]
  14. Int J Mol Sci. 2020 Apr 24;21(8): [PMID: 32344772]
  15. Neural Regen Res. 2024 Jun 1;19(6):1241-1248 [PMID: 37905870]
  16. Nat Rev Immunol. 2020 Mar;20(3):143-157 [PMID: 31690840]
  17. Arch Neurol. 2010 Jun;67(6):731-8 [PMID: 20558392]
  18. Neuropathol Appl Neurobiol. 2013 Feb;39(1):19-34 [PMID: 23039106]
  19. Neurochem Res. 2024 Apr;49(4):834-846 [PMID: 38227113]
  20. Neural Regen Res. 2025 Mar 1;20(3):817-818 [PMID: 38886953]
  21. Front Neurosci. 2019 Sep 24;13:1028 [PMID: 31611767]
  22. Nature. 2017 Jul 6;547(7661):99-103 [PMID: 28459430]
  23. Cell Death Dis. 2023 Mar 1;14(3):176 [PMID: 36859484]
  24. Cells. 2019 Oct 22;8(10): [PMID: 31652490]
  25. Neural Regen Res. 2024 May;19(5):998-1005 [PMID: 37862201]
  26. Science. 2021 Jun 25;372(6549): [PMID: 35058659]
  27. Int J Mol Sci. 2022 Dec 05;23(23): [PMID: 36499659]
  28. J Neuroimmunol. 2003 Nov;144(1-2):139-42 [PMID: 14597108]
  29. Mol Cell Neurosci. 2021 Sep;115:103657 [PMID: 34314836]
  30. Trends Neurosci. 2002 Jan;25(1):22-6 [PMID: 11801334]
  31. J Neuroinflammation. 2022 Aug 17;19(1):206 [PMID: 35978311]
  32. Nat Cell Biol. 2023 Jul;25(7):963-974 [PMID: 37231161]
  33. Stroke. 2011 Sep;42(9):2589-94 [PMID: 21737799]
  34. Ann Neurol. 2019 Feb;85(2):229-240 [PMID: 30597624]
  35. Brain Behav Immun. 2021 Jan;91:324-338 [PMID: 33039664]
  36. Alzheimers Dement (N Y). 2024 Jan 26;10(1):e12445 [PMID: 38528988]
  37. J Neuroimmunol. 2017 Feb 15;303:90-98 [PMID: 28087076]
  38. Cancers (Basel). 2022 Nov 26;14(23): [PMID: 36497321]
  39. Lancet Neurol. 2022 Aug;21(8):726-734 [PMID: 35643092]
  40. J Exp Med. 2005 Mar 21;201(6):915-23 [PMID: 15767370]
  41. Int J Mol Sci. 2022 Sep 12;23(18): [PMID: 36142483]
  42. PLoS One. 2013 Aug 13;8(8):e72698 [PMID: 23967334]
  43. Cardiovasc Toxicol. 2016 Apr;16(2):111-21 [PMID: 25800750]
  44. Front Immunol. 2018 Sep 19;9:2122 [PMID: 30283455]
  45. Cells. 2019 Jun 04;8(6): [PMID: 31167518]
  46. Int J Mol Med. 2023 Nov;52(5): [PMID: 37800614]
  47. Sci Rep. 2024 Feb 7;14(1):3145 [PMID: 38326384]
  48. Front Immunol. 2017 May 18;8:531 [PMID: 28572801]
  49. Cells. 2020 Dec 07;9(12): [PMID: 33297340]
  50. CNS Neurol Disord Drug Targets. 2010 Apr;9(2):156-67 [PMID: 20205644]
  51. Cell. 2019 Jul 25;178(3):536-551.e14 [PMID: 31257024]
  52. Stroke. 2016 Feb;47(2):498-504 [PMID: 26732561]
  53. Nat Rev Clin Oncol. 2020 Jul;17(7):395-417 [PMID: 32203277]
  54. Biomedicines. 2022 Mar 23;10(4): [PMID: 35453503]
  55. Mediators Inflamm. 2021 May 31;2021:9999146 [PMID: 34158806]
  56. Autophagy. 2016 Sep;12(9):1575-92 [PMID: 27310465]
  57. F1000Res. 2018 Jul 31;7: [PMID: 30135715]
  58. Front Immunol. 2017 Mar 02;8:198 [PMID: 28303137]
  59. Cell. 2023 Feb 16;186(4):693-714 [PMID: 36803602]
  60. Mol Neurodegener. 2021 Jul 2;16(1):44 [PMID: 34215308]
  61. Neurosci Biobehav Rev. 2006;30(6):791-807 [PMID: 16901542]
  62. Front Pharmacol. 2022 Dec 22;13:1094351 [PMID: 36618946]
  63. Toxicol Pathol. 2007 Jun;35(4):495-516 [PMID: 17562483]
  64. Neurosci Bull. 2024 Mar;40(3):363-382 [PMID: 37856037]
  65. Sci Rep. 2017 Aug 22;7(1):9094 [PMID: 28831083]
  66. Mol Immunol. 2022 Nov;151:134-142 [PMID: 36126501]
  67. Aging Dis. 2019 Dec 1;10(6):1207-1220 [PMID: 31788333]
  68. Eur Respir Rev. 2022 Dec 21;31(166): [PMID: 36543345]
  69. Brain Res. 2016 Mar 1;1634:34-44 [PMID: 26607252]
  70. Curr Psychiatry Rep. 2010 Feb;12(1):39-45 [PMID: 20425309]
  71. Lancet Reg Health Eur. 2024 Feb 09;39:100870 [PMID: 38361749]
  72. Cell Rep. 2021 Jan 12;34(2):108615 [PMID: 33440141]
  73. BMC Dev Biol. 2005 Aug 18;5:17 [PMID: 16109169]
  74. Folia Neuropathol. 2019;57(2):87-105 [PMID: 31556570]
  75. J Biol Chem. 2000 Jul 28;275(30):23340-5 [PMID: 10811644]
  76. Neural Regen Res. 2025 Apr 1;20(4):973-989 [PMID: 38989932]
  77. Trends Immunol. 2015 Jun;36(6):364-73 [PMID: 26001312]
  78. Nat Rev Neurol. 2015 Jan;11(1):56-64 [PMID: 25385337]
  79. Cardiovasc Res. 2022 Mar 16;118(4):934-950 [PMID: 33956077]
  80. Front Immunol. 2023 Feb 23;14:1134661 [PMID: 36911661]
  81. Nature. 2014 Nov 13;515(7526):299-300 [PMID: 25396246]
  82. Int J Mol Sci. 2021 Mar 24;22(7): [PMID: 33805142]
  83. Mol Cell Biochem. 2023 Jun;478(6):1307-1324 [PMID: 36308670]
  84. Int J Mol Sci. 2021 Apr 14;22(8): [PMID: 33920048]
  85. Front Immunol. 2023 Aug 23;14:1193081 [PMID: 37680624]
  86. Front Cell Neurosci. 2014 Apr 22;8:112 [PMID: 24795567]
  87. Inflammopharmacology. 2013 Aug;21(4):309-20 [PMID: 23296919]
  88. Sci Transl Med. 2023 May 10;15(695):eabq6089 [PMID: 37163617]
  89. Cold Spring Harb Perspect Biol. 2013 Apr 01;5(4):a008656 [PMID: 23545416]
  90. Genome Med. 2023 Jan 26;15(1):6 [PMID: 36703235]
  91. Nat Commun. 2023 Mar 25;14(1):1670 [PMID: 36966157]
  92. Cells. 2024 Mar 11;13(6): [PMID: 38534329]
  93. Int J Mol Sci. 2021 Dec 10;22(24): [PMID: 34948108]
  94. Neurobiol Dis. 2018 Jan;109(Pt B):249-257 [PMID: 28400134]
  95. Nat Rev Drug Discov. 2024 Nov;23(11):862-879 [PMID: 39261632]
  96. Brain Res. 2023 Nov 15;1819:148518 [PMID: 37579986]
  97. Int J Mol Sci. 2023 Aug 19;24(16): [PMID: 37629148]
  98. Cureus. 2022 Aug 27;14(8):e28484 [PMID: 36176885]
  99. Molecules. 2023 Jun 01;28(11): [PMID: 37298976]
  100. iScience. 2024 Mar 30;27(5):109651 [PMID: 38638574]
  101. Cold Spring Harb Perspect Med. 2017 Jul 5;7(7): [PMID: 27940602]
  102. Arch Intern Med. 2007 Apr 9;167(7):635-41 [PMID: 17420420]
  103. Fluids Barriers CNS. 2016 Aug 08;13(1):14 [PMID: 27503326]
  104. Immunity. 2023 Nov 14;56(11):2523-2541.e8 [PMID: 37924812]
  105. Nat Immunol. 2010 May;11(5):373-84 [PMID: 20404851]
  106. Mitochondrion. 2023 May;70:8-19 [PMID: 36906250]
  107. Neurobiol Dis. 1998 Apr;4(6):387-97 [PMID: 9666478]
  108. Lancet. 2021 Apr 24;397(10284):1577-1590 [PMID: 33667416]
  109. Neuroscientist. 2010 Aug;16(4):408-20 [PMID: 20817918]
  110. Brain Res Mol Brain Res. 2000 Apr 14;77(1):138-47 [PMID: 10814840]
  111. J Neurochem. 2001 Mar;76(6):1895-904 [PMID: 11259508]
  112. Cell Death Differ. 2024 Apr;31(4):469-478 [PMID: 38503846]
  113. Free Radic Biol Med. 2022 Mar;182:93-99 [PMID: 35202786]
  114. Annu Rev Immunol. 2020 Apr 26;38:455-485 [PMID: 32004099]
  115. Neurochem Int. 2021 Sep;148:105080 [PMID: 34048845]
  116. Annu Rev Immunol. 2009;27:693-733 [PMID: 19302050]
  117. Mol Cells. 2022 Mar 31;45(3):134-147 [PMID: 34887364]
  118. J Cell Biochem. 2008 Jul 1;104(4):1393-406 [PMID: 18286508]
  119. Nat Genet. 1998 Feb;18(2):150-4 [PMID: 9462744]
  120. Brain Sci. 2024 Jan 17;14(1): [PMID: 38248303]
  121. Front Pharmacol. 2024 Jan 22;15:1333006 [PMID: 38318134]
  122. Mol Aspects Med. 2021 Dec;82:100972 [PMID: 34130867]
  123. PLoS One. 2013 May 14;8(5):e64368 [PMID: 23691206]
  124. J Neurol Neurosurg Spine. 2016;1(1): [PMID: 28127589]
  125. Int J Neurosci. 2017 Jul;127(7):624-633 [PMID: 27412492]
  126. Immunity. 2015 Nov 17;43(5):923-32 [PMID: 26572062]
  127. Nat Rev Immunol. 2022 Nov;22(11):657-673 [PMID: 35246670]
  128. Clin Sci (Lond). 2022 May 27;136(10):733-746 [PMID: 35608088]
  129. Brain Res Bull. 2023 Dec;205:110828 [PMID: 38029846]
  130. Glia. 2007 Nov 15;55(15):1519-30 [PMID: 17705199]
  131. J Neuroinflammation. 2018 May 29;15(1):170 [PMID: 29843759]
  132. Physiology (Bethesda). 2015 Sep;30(5):371-88 [PMID: 26328882]
  133. Front Immunol. 2023 Jul 07;14:1213448 [PMID: 37483590]
  134. Acta Neuropathol Commun. 2020 Apr 15;8(1):47 [PMID: 32293551]
  135. Prog Neurobiol. 2016 Jul;142:23-44 [PMID: 27166859]
  136. J Med Biochem. 2016 Apr;35(2):150-157 [PMID: 28356875]
  137. Nat Neurosci. 2022 May;25(5):588-595 [PMID: 35513515]
  138. Neuroreport. 2009 Aug 5;20(12):1098-103 [PMID: 19590393]
  139. J Neurosci. 1999 Feb 15;19(4):1189-202 [PMID: 9952397]
  140. Cell Mol Immunol. 2019 Jun;16(6):523-530 [PMID: 30846842]
  141. NPJ Parkinsons Dis. 2023 Feb 2;9(1):14 [PMID: 36732520]
  142. Cells. 2024 Mar 14;13(6): [PMID: 38534355]
  143. Sci Adv. 2023 Oct 6;9(40):eadi8343 [PMID: 37801503]
  144. Mol Neurobiol. 2016 Aug;53(6):4094-4125 [PMID: 26198567]
  145. EMBO J. 2004 Oct 27;23(21):4307-18 [PMID: 15470501]
  146. Mol Cell. 2015 Aug 20;59(4):677-84 [PMID: 26236013]
  147. Mol Med Rep. 2020 May;21(5):2006-2018 [PMID: 32323760]
  148. Acta Pharmacol Sin. 2022 Oct;43(10):2439-2447 [PMID: 35233090]
  149. Free Radic Biol Med. 2023 Nov 1;208:846-858 [PMID: 37776918]
  150. Brain Behav Immun. 2018 Feb;68:98-110 [PMID: 29030217]
  151. Int J Biol Macromol. 2021 Mar 1;172:93-103 [PMID: 33440210]
  152. Cell. 2015 Jan 15;160(1-2):62-73 [PMID: 25594175]
  153. Brain Behav Immun. 2020 Jul;87:498-507 [PMID: 32027960]
  154. Pharmacol Ther. 2021 Apr;220:107716 [PMID: 33164782]
  155. Biomed Pharmacother. 2022 Feb;146:112545 [PMID: 34922112]
  156. EMBO J. 2023 Mar 1;42(5):e110468 [PMID: 36647737]
  157. Cell Death Discov. 2018 Feb 2;4:8 [PMID: 29531805]
  158. Am J Physiol Gastrointest Liver Physiol. 2020 Nov 1;319(5):G529-G540 [PMID: 32877215]
  159. Sci Rep. 2023 Jan 16;13(1):826 [PMID: 36646730]
  160. Neural Regen Res. 2023 Jun;18(6):1165-1178 [PMID: 36453390]
  161. J Pathol. 2023 Mar;259(3):331-341 [PMID: 36484734]
  162. Nat Rev Immunol. 2014 Jul;14(7):463-77 [PMID: 24962261]
  163. Neurosci Insights. 2021 May 25;16:26331055211018458 [PMID: 34104887]
  164. J Integr Neurosci. 2024 Dec 24;23(12):223 [PMID: 39735965]
  165. Neuron. 1995 May;14(5):1075-81 [PMID: 7748555]
  166. Cell Res. 2015 Dec;25(12):1285-98 [PMID: 26611636]
  167. Cell Rep. 2021 May 11;35(6):109112 [PMID: 33979622]
  168. Antioxidants (Basel). 2023 Jan 06;12(1): [PMID: 36671004]
  169. Neurochem Res. 2023 Nov;48(11):3378-3390 [PMID: 37436612]
  170. Cell. 2006 Feb 24;124(4):783-801 [PMID: 16497588]
  171. Brain Sci. 2021 Jul 09;11(7): [PMID: 34356139]
  172. Fly (Austin). 2024 Dec;18(1):2306687 [PMID: 38286464]
  173. Antioxidants (Basel). 2020 Sep 22;9(9): [PMID: 32971909]
  174. Trends Neurosci. 2017 Jun;40(6):358-370 [PMID: 28527591]
  175. Mol Neurobiol. 2017 Oct;54(8):6287-6303 [PMID: 27714635]
  176. Aging Dis. 2024 May 7;15(3):1075-1107 [PMID: 37728583]
  177. Cell. 2006 Jun 2;125(5):943-55 [PMID: 16751103]
  178. J Neuroinflammation. 2024 Mar 30;21(1):80 [PMID: 38555419]
  179. Brain Res. 2019 Mar 15;1707:8-17 [PMID: 30445026]
  180. Annu Rev Immunol. 2017 Apr 26;35:441-468 [PMID: 28226226]
  181. Front Mol Neurosci. 2022 Aug 02;15:954541 [PMID: 35983068]
  182. Int J Mol Sci. 2021 Mar 08;22(5): [PMID: 33800290]
  183. Transl Neurodegener. 2020 Nov 26;9(1):42 [PMID: 33239064]
  184. J Pharmacol Exp Ther. 2023 Jan;384(1):205-223 [PMID: 36310035]
  185. Mol Biol Cell. 2001 May;12(5):1393-407 [PMID: 11359930]
  186. Int J Mol Sci. 2023 Mar 30;24(7): [PMID: 37047492]
  187. Front Neurosci. 2022 Dec 21;16:1029473 [PMID: 36620455]
  188. Signal Transduct Target Ther. 2023 Jul 12;8(1):267 [PMID: 37433768]
  189. Int J Mol Sci. 2019 Nov 28;20(23): [PMID: 31795242]
  190. Neural Regen Res. 2024 Jul 1;19(7):1584-1592 [PMID: 38051903]
  191. Aging Dis. 2020 Jul 23;11(4):946-966 [PMID: 32765956]
  192. Foods. 2024 Jun 05;13(11): [PMID: 38891002]
  193. Brain Res Bull. 2024 Jul;213:110988 [PMID: 38805766]
  194. J Cell Mol Med. 2008 Jan-Feb;12(1):38-55 [PMID: 18194444]
  195. Am J Respir Cell Mol Biol. 2023 Apr;68(4):444-455 [PMID: 36608844]
  196. Science. 2016 Aug 19;353(6301):777-83 [PMID: 27540165]
  197. Cell Mol Life Sci. 2020 Dec;77(24):5171-5188 [PMID: 32617639]
  198. Neuroreport. 2024 Jul 1;35(10):664-672 [PMID: 38813905]
  199. Sci Signal. 2023 Jan 31;16(770):eabo4314 [PMID: 36719944]
  200. Ageing Res Rev. 2024 Jun;97:102288 [PMID: 38580172]
  201. Neurobiol Dis. 2020 Sep;143:104963 [PMID: 32593752]
  202. Front Immunol. 2020 May 08;11:760 [PMID: 32457742]
  203. Biomed Res Int. 2023 May 27;2023:3483411 [PMID: 37274074]
  204. J Biol Chem. 2010 Apr 2;285(14):10653-61 [PMID: 20145253]
  205. Front Cell Neurosci. 2021 Nov 24;15:749587 [PMID: 34899188]
  206. J Clin Invest. 2021 Jun 15;131(12): [PMID: 34128471]
  207. Genomics. 2007 May;89(5):618-29 [PMID: 17350798]
  208. Signal Transduct Target Ther. 2020 Sep 21;5(1):209 [PMID: 32958760]
  209. Semin Immunol. 2023 Sep;69:101781 [PMID: 37352727]
  210. Trends Neurosci. 2024 Apr;47(4):289-302 [PMID: 38521710]
  211. Autophagy. 2016 May 3;12(5):814-32 [PMID: 26986811]
  212. Front Immunol. 2022 Nov 11;13:1044662 [PMID: 36439136]
  213. Mol Neurobiol. 2010 Jun;41(2-3):115-28 [PMID: 20195797]
  214. Free Radic Biol Med. 2008 Dec 15;45(12):1695-704 [PMID: 18852043]
  215. Acta Pharmacol Sin. 2023 Dec;44(12):2358-2375 [PMID: 37550526]
  216. Annu Rev Biochem. 2004;73:87-106 [PMID: 15189137]
  217. Neural Regen Res. 2023 Nov;18(11):2436-2442 [PMID: 37282474]
  218. Front Cell Neurosci. 2019 Mar 19;13:103 [PMID: 30941017]
  219. Neurochem Int. 2024 Sep;178:105772 [PMID: 38789043]
  220. Genes Dis. 2020 Jul 18;8(3):287-297 [PMID: 33997176]
  221. Nature. 2015 Oct 29;526(7575):660-5 [PMID: 26375003]
  222. Sci Rep. 2022 Oct 25;12(1):17908 [PMID: 36284170]
  223. Exp Ther Med. 2020 Mar;19(3):1997-2007 [PMID: 32104259]
  224. Curr Neuropharmacol. 2022;20(6):1116-1143 [PMID: 34852742]
  225. Br J Pharmacol. 2016 Feb;173(4):692-702 [PMID: 25752446]
  226. ACS Pharmacol Transl Sci. 2022 Dec 14;6(1):40-51 [PMID: 36654754]
  227. Nat Genet. 2003 Sep;35(1):76-83 [PMID: 12881722]
  228. Front Aging Neurosci. 2023 Nov 09;15:1284214 [PMID: 38020781]
  229. Cell Mol Biol Lett. 2024 Jan 16;29(1):13 [PMID: 38225560]
  230. Trends Neurosci. 2021 Feb;44(2):83-96 [PMID: 33187730]
  231. Microbiome. 2021 Nov 17;9(1):226 [PMID: 34784980]
  232. Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a001651 [PMID: 20457564]
  233. J Mol Cell Cardiol. 2023 Jan;174:47-55 [PMID: 36410526]
  234. J Exp Med. 2008 Aug 4;205(8):1869-77 [PMID: 18625748]
  235. Nat Commun. 2017 Jan 03;8:14128 [PMID: 28045099]
  236. Nutr Res. 2024 Jan;121:39-50 [PMID: 38039600]
  237. Signal Transduct Target Ther. 2024 Aug 23;9(1):211 [PMID: 39174535]
  238. Biomed Pharmacother. 2018 Sep;105:518-525 [PMID: 29883947]
  239. Nat Neurosci. 2020 Nov;23(11):1339-1351 [PMID: 33077946]
  240. Adv Immunol. 2017;135:81-117 [PMID: 28826530]
  241. Nat Rev Immunol. 2017 Jan;17(1):49-59 [PMID: 27916979]
  242. Environ Pollut. 2021 Apr 1;274:116497 [PMID: 33540250]
  243. Neural Regen Res. 2024 Sep 1;19(9):1991-1997 [PMID: 38227527]
  244. J Cereb Blood Flow Metab. 2009 Sep;29(9):1503-16 [PMID: 19471279]
  245. Biomolecules. 2020 Jul 01;10(7): [PMID: 32630239]
  246. Nature. 2015 Aug 20;524(7565):309-314 [PMID: 26266977]
  247. Nature. 2001 Jul 12;412(6843):143-4 [PMID: 11449262]
  248. Neural Regen Res. 2024 Aug 1;19(8):1828-1834 [PMID: 38103250]
  249. Inflammation. 2025 Feb;48(1):361-371 [PMID: 38878150]
  250. Neural Regen Res. 2024 Jan;19(1):69-74 [PMID: 37488846]
  251. Bioorg Chem. 2020 Mar;96:103611 [PMID: 32007723]
  252. Biomedicines. 2021 May 07;9(5): [PMID: 34067173]
  253. Gut Microbes. 2021 Jan 1;13(1):1866974 [PMID: 33459114]
  254. Neuroscience. 2024 Dec 6;562:43-53 [PMID: 39454716]
  255. J Neuroinflammation. 2021 Nov 27;18(1):276 [PMID: 34838047]
  256. J Ginseng Res. 2024 Jan;48(1):1-11 [PMID: 38223830]
  257. Cell Mol Immunol. 2019 Jun;16(6):540-546 [PMID: 30874626]
  258. Front Immunol. 2021 Aug 09;12:716469 [PMID: 34434197]
  259. Nat Rev Immunol. 2022 Dec;22(12):734-750 [PMID: 35508809]
  260. ACS Chem Neurosci. 2022 Jan 19;13(2):207-216 [PMID: 34965724]
  261. Mediators Inflamm. 2013;2013:893521 [PMID: 23935250]
  262. Exp Mol Pathol. 2023 Feb;129:104846 [PMID: 36436571]
  263. Neuron. 2002 Aug 1;35(3):419-32 [PMID: 12165466]
  264. Adv Exp Med Biol. 2019;1175:181-197 [PMID: 31583589]
  265. Cell. 2008 Feb 8;132(3):344-62 [PMID: 18267068]
  266. J Neuroimmunol. 2014 Dec 15;277(1-2):153-9 [PMID: 25457841]
  267. Cell Death Dis. 2019 Feb 21;10(3):177 [PMID: 30792387]
  268. J Neuroinflammation. 2018 Sep 24;15(1):276 [PMID: 30249283]
  269. Nat Rev Immunol. 2017 Sep;17(9):545-558 [PMID: 28580957]
  270. Commun Biol. 2020 Feb 18;3(1):79 [PMID: 32071389]
  271. Curr Atheroscler Rep. 2023 Oct;25(10):741-749 [PMID: 37665492]
  272. Neural Regen Res. 2023 Sep;18(9):1908-1916 [PMID: 36926707]
  273. Apoptosis. 2023 Feb;28(1-2):20-38 [PMID: 36342579]
  274. Genes Dev. 2020 Mar 1;34(5-6):428-445 [PMID: 32001510]
  275. Front Pharmacol. 2021 Apr 15;12:648636 [PMID: 33935751]

Word Cloud

Similar Articles

Cited By